| Line |
Concept |
Weight |
Decimals |
Precision |
Reported |
Calculated |
Source |
Message |
| 1 |
Extended Link [
http://biogenidec.com/20090630/StatementsOfCashFlows
]
|
| 2 |
Context
SixMonthsEnded_30Jun2008
[
2008-01-01
-
2008-06-30
]
|
| c-equal |
|
| 3 |
Unit
USD
|
| u-equal |
|
|
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease |
|
-3 |
[6] |
-195300000 |
-195,300,000 |
Instance |
OK |
|
us-gaap:NetCashProvidedByUsedInOperatingActivities |
1.0 |
-3 |
[6] |
643007000 |
139,079,000 |
Instance |
Inconsistency found, calculated value is
139,079,000
|
|
biib:ProfitLoss |
-1.0 |
-3 |
[6] |
373880000 |
373,880,000 |
Instance |
|
|
us-gaap:DepreciationAndAmortization |
1.0 |
-3 |
[6] |
212471000 |
212,471,000 |
Instance |
|
|
us-gaap:ResearchAndDevelopmentInProcess |
1.0 |
-3 |
[5] |
25000000 |
25,000,000 |
Instance |
|
|
us-gaap:ShareBasedCompensation |
1.0 |
-3 |
[5] |
67647000 |
67,647,000 |
Instance |
|
|
us-gaap:OtherNoncashExpense |
1.0 |
-3 |
[5] |
12151000 |
12,151,000 |
Instance |
|
|
us-gaap:DeferredIncomeTaxExpenseBenefit |
1.0 |
-3 |
[5] |
-14757000 |
-14,757,000 |
Instance |
|
|
us-gaap:GainLossOnInvestments |
1.0 |
-3 |
[4] |
-5928000 |
-5,928,000 |
Instance |
|
|
us-gaap:WriteOffOfInventory |
1.0 |
-3 |
[4] |
9838000 |
9,838,000 |
Instance |
|
|
us-gaap:ImpairmentOfInvestments |
1.0 |
-3 |
[5] |
15451000 |
15,451,000 |
Instance |
|
|
us-gaap:IncreaseDecreaseInAccountsReceivable |
-1.0 |
-3 |
[5] |
-86302000 |
-86,302,000 |
Instance |
|
|
biib:IncreaseDecreaseInDueFromUnconsolidatedJointBusiness |
1.0 |
-3 |
[5] |
-17535000 |
-17,535,000 |
Instance |
|
|
us-gaap:IncreaseDecreaseInInventories |
-1.0 |
-3 |
[5] |
-28187000 |
-28,187,000 |
Instance |
|
|
us-gaap:IncreaseDecreaseInOtherOperatingAssets |
-1.0 |
-3 |
[4] |
-7427000 |
-7,427,000 |
Instance |
|
|
us-gaap:IncreaseDecreaseInAccruedLiabilities |
1.0 |
-3 |
[6] |
101412000 |
101,412,000 |
Instance |
|
|
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities |
1.0 |
-3 |
[4] |
3741000 |
3,741,000 |
Instance |
|
|
us-gaap:ExcessTaxBenefitFromShareBasedCompensationOperatingActivities |
1.0 |
-3 |
[5] |
-18448000 |
-18,448,000 |
Instance |
|
|
us-gaap:NetCashProvidedByUsedInInvestingActivities |
1.0 |
-3 |
[6] |
199354000 |
2,707,080,000 |
Instance |
Inconsistency found, calculated value is
2,707,080,000
|
|
biib:ProceedsFromSaleOfStrategicEquityInvestment |
1.0 |
-3 |
[2] |
15000 |
15,000 |
Instance |
|
|
biib:CollateralReceivedUnderSecuritiesLending |
1.0 |
-3 |
[5] |
61253000 |
61,253,000 |
Instance |
|
|
us-gaap:PaymentsToAcquireMarketableSecurities |
-1.0 |
-3 |
[7] |
-1060159000 |
-1,060,159,000 |
Instance |
|
|
us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities |
1.0 |
-3 |
[7] |
1391949000 |
1,391,949,000 |
Instance |
|
|
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired |
-1.0 |
-3 |
[5] |
-25000000 |
-25,000,000 |
Instance |
|
|
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
-1.0 |
-3 |
[6] |
-157093000 |
-157,093,000 |
Instance |
|
|
us-gaap:PaymentsToAcquireOtherInvestments |
-1.0 |
-3 |
[5] |
-11611000 |
-11,611,000 |
Instance |
|
|
us-gaap:NetCashProvidedByUsedInFinancingActivities |
1.0 |
-3 |
[7] |
-1037661000 |
3,229,327,000 |
Instance |
Inconsistency found, calculated value is
3,229,327,000
|
|
us-gaap:PaymentsForRepurchaseOfCommonStock |
-1.0 |
-3 |
[6] |
-559767000 |
-559,767,000 |
Instance |
|
|
us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans |
1.0 |
-3 |
[5] |
89532000 |
89,532,000 |
Instance |
|
|
us-gaap:ProceedsFromRepaymentsOfBankOverdrafts |
1.0 |
-3 |
[3] |
873000 |
873,000 |
Instance |
|
|
us-gaap:ProceedsFromShortTermDebt |
1.0 |
-3 |
[6] |
986980000 |
986,980,000 |
Instance |
|
|
us-gaap:RepaymentsOfShortTermDebt |
-1.0 |
-3 |
[7] |
-1512474000 |
-1,512,474,000 |
Instance |
|
|
biib:ObligationUnderSecuritiesLending |
-1.0 |
-3 |
[5] |
-61253000 |
-61,253,000 |
Instance |
|
|
us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities |
1.0 |
-3 |
[5] |
18448000 |
18,448,000 |
Instance |
|
| 2 |
Context
January-01-2009_June-30-2009
[
2009-01-01
-
2009-06-30
]
|
| c-equal |
|
| 3 |
Unit
USD
|
| u-equal |
|
|
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease |
|
-3 |
[6] |
162304000 |
162,304,000 |
Instance |
OK |
|
us-gaap:NetCashProvidedByUsedInOperatingActivities |
1.0 |
-3 |
[6] |
529301000 |
-86,163,000 |
Instance |
Inconsistency found, calculated value is
-86,163,000
|
|
biib:ProfitLoss |
-1.0 |
-3 |
[6] |
391464000 |
391,464,000 |
Instance |
|
|
us-gaap:DepreciationAndAmortization |
1.0 |
-3 |
[6] |
248877000 |
248,877,000 |
Instance |
|
|
us-gaap:ResearchAndDevelopmentInProcess |
1.0 |
-3 |
[0] |
0 |
0 |
Instance |
|
|
us-gaap:ShareBasedCompensation |
1.0 |
-3 |
[5] |
78892000 |
78,892,000 |
Instance |
|
|
us-gaap:OtherNoncashExpense |
1.0 |
-3 |
[4] |
-7592000 |
-7,592,000 |
Instance |
|
|
us-gaap:DeferredIncomeTaxExpenseBenefit |
1.0 |
-3 |
[5] |
-42772000 |
-42,772,000 |
Instance |
|
|
us-gaap:GainLossOnInvestments |
1.0 |
-3 |
[5] |
-15434000 |
-15,434,000 |
Instance |
|
|
us-gaap:WriteOffOfInventory |
1.0 |
-3 |
[5] |
11475000 |
11,475,000 |
Instance |
|
|
us-gaap:ImpairmentOfInvestments |
1.0 |
-3 |
[5] |
10002000 |
10,002,000 |
Instance |
|
|
us-gaap:IncreaseDecreaseInAccountsReceivable |
-1.0 |
-3 |
[5] |
-63842000 |
-63,842,000 |
Instance |
|
|
biib:IncreaseDecreaseInDueFromUnconsolidatedJointBusiness |
1.0 |
-3 |
[4] |
8719000 |
8,719,000 |
Instance |
|
|
us-gaap:IncreaseDecreaseInInventories |
-1.0 |
-3 |
[5] |
-14353000 |
-14,353,000 |
Instance |
|
|
us-gaap:IncreaseDecreaseInOtherOperatingAssets |
-1.0 |
-3 |
[4] |
-5537000 |
-5,537,000 |
Instance |
|
|
us-gaap:IncreaseDecreaseInAccruedLiabilities |
1.0 |
-3 |
[5] |
22950000 |
22,950,000 |
Instance |
|
|
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities |
1.0 |
-3 |
[5] |
-90748000 |
-90,748,000 |
Instance |
|
|
us-gaap:ExcessTaxBenefitFromShareBasedCompensationOperatingActivities |
1.0 |
-3 |
[4] |
-2800000 |
-2,800,000 |
Instance |
|
|
us-gaap:NetCashProvidedByUsedInInvestingActivities |
1.0 |
-3 |
[6] |
-303220000 |
3,649,460,000 |
Instance |
Inconsistency found, calculated value is
3,649,460,000
|
|
biib:ProceedsFromSaleOfStrategicEquityInvestment |
1.0 |
-3 |
[4] |
5565000 |
5,565,000 |
Instance |
|
|
biib:CollateralReceivedUnderSecuritiesLending |
1.0 |
-3 |
[5] |
29991000 |
29,991,000 |
Instance |
|
|
us-gaap:PaymentsToAcquireMarketableSecurities |
-1.0 |
-3 |
[7] |
-1869415000 |
-1,869,415,000 |
Instance |
|
|
us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities |
1.0 |
-3 |
[7] |
1637562000 |
1,637,562,000 |
Instance |
|
|
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired |
-1.0 |
-3 |
[0] |
0 |
0 |
Instance |
|
|
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
-1.0 |
-3 |
[5] |
-71721000 |
-71,721,000 |
Instance |
|
|
us-gaap:PaymentsToAcquireOtherInvestments |
-1.0 |
-3 |
[5] |
-35202000 |
-35,202,000 |
Instance |
|
|
us-gaap:NetCashProvidedByUsedInFinancingActivities |
1.0 |
-3 |
[5] |
-63777000 |
133,200,000 |
Instance |
Inconsistency found, calculated value is
133,200,000
|
|
us-gaap:PaymentsForRepurchaseOfCommonStock |
-1.0 |
-3 |
[5] |
-57631000 |
-57,631,000 |
Instance |
|
|
us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans |
1.0 |
-3 |
[5] |
24387000 |
24,387,000 |
Instance |
|
|
us-gaap:ProceedsFromRepaymentsOfBankOverdrafts |
1.0 |
-3 |
[4] |
7525000 |
7,525,000 |
Instance |
|
|
us-gaap:ProceedsFromShortTermDebt |
1.0 |
-3 |
[0] |
0 |
0 |
Instance |
|
|
us-gaap:RepaymentsOfShortTermDebt |
-1.0 |
-3 |
[5] |
-10867000 |
-10,867,000 |
Instance |
|
|
biib:ObligationUnderSecuritiesLending |
-1.0 |
-3 |
[5] |
-29991000 |
-29,991,000 |
Instance |
|
|
us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities |
1.0 |
-3 |
[4] |
2800000 |
2,800,000 |
Instance |
|
|
| 1 |
Extended Link [
http://biogenidec.com/20090630/BalanceSheets
]
|
| 2 |
Context
BalanceAsOf_30Jun2009
[
2009-06-30
-
]
|
| c-equal |
|
| 3 |
Unit
USD
|
| u-equal |
|
|
us-gaap:LiabilitiesAndStockholdersEquity |
|
-3 |
[7] |
8777196000 |
8,777,196,000 |
Instance |
OK |
|
us-gaap:Liabilities |
1.0 |
-3 |
[7] |
2531491000 |
2,531,491,000 |
Instance |
OK |
|
us-gaap:LiabilitiesCurrent |
1.0 |
-3 |
[6] |
803926000 |
803,926,000 |
Instance |
OK |
|
biib:CollateralPayableOnLoanedSecurities |
1.0 |
-3 |
[0] |
0 |
0 |
Instance |
|
|
us-gaap:AccountsPayable |
1.0 |
-3 |
[6] |
210941000 |
210,941,000 |
Instance |
|
|
us-gaap:TaxesPayable |
1.0 |
-3 |
[5] |
81594000 |
81,594,000 |
Instance |
|
|
us-gaap:OtherLiabilitiesCurrent |
1.0 |
-3 |
[6] |
496694000 |
496,694,000 |
Instance |
|
|
us-gaap:NotesPayableCurrent |
1.0 |
-3 |
[5] |
14697000 |
14,697,000 |
Instance |
|
|
us-gaap:LongTermNotesPayable |
1.0 |
-3 |
[7] |
1085607000 |
1,085,607,000 |
Instance |
|
|
us-gaap:DeferredTaxLiabilitiesNoncurrent |
1.0 |
-3 |
[6] |
310962000 |
310,962,000 |
Instance |
|
|
us-gaap:OtherLiabilitiesNoncurrent |
1.0 |
-3 |
[6] |
330996000 |
330,996,000 |
Instance |
|
|
us-gaap:StockholdersEquity |
1.0 |
-3 |
[7] |
6245705000 |
6,245,705,000 |
Instance |
OK |
|
biib:NoncontrollingInterest |
1.0 |
-3 |
[5] |
33167000 |
33,167,000 |
Instance |
|
|
biib:TotalShareholdersEquityBeforeNoncontrollingInterest |
1.0 |
-3 |
[7] |
6212538000 |
7,129,482,000 |
Instance |
Inconsistency found, calculated value is
7,129,482,000
|
|
us-gaap:AdditionalPaidInCapital |
1.0 |
-3 |
[7] |
6142936000 |
6,142,936,000 |
Instance |
|
|
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax |
1.0 |
-3 |
[5] |
11293000 |
11,293,000 |
Instance |
|
|
us-gaap:RetainedEarningsAccumulatedDeficit |
1.0 |
-3 |
[6] |
516632000 |
516,632,000 |
Instance |
|
|
us-gaap:TreasuryStockValue |
-1.0 |
-3 |
[6] |
-458472000 |
-458,472,000 |
Instance |
|
|
us-gaap:CommonStockValue |
1.0 |
-3 |
[3] |
149000 |
149,000 |
Instance |
|
|
us-gaap:PreferredStockValue |
1.0 |
-3 |
[0] |
0 |
0 |
Instance |
|
|
us-gaap:Assets |
|
-3 |
[7] |
8777196000 |
8,777,196,000 |
Instance |
OK |
|
us-gaap:AssetsCurrent |
1.0 |
-3 |
[7] |
2744278000 |
2,744,278,000 |
Instance |
OK |
|
us-gaap:CashAndCashEquivalentsAtCarryingValue |
1.0 |
-3 |
[6] |
786804000 |
786,804,000 |
Instance |
|
|
us-gaap:MarketableSecuritiesCurrent |
1.0 |
-3 |
[6] |
836270000 |
836,270,000 |
Instance |
|
|
biib:CollateralReceivedForLoanedSecurities |
1.0 |
-3 |
[0] |
0 |
0 |
Instance |
|
|
us-gaap:AccountsReceivableNetCurrent |
1.0 |
-3 |
[6] |
511286000 |
511,286,000 |
Instance |
|
|
biib:DueFromUnconsolidatedJointBusiness |
1.0 |
-3 |
[6] |
198206000 |
198,206,000 |
Instance |
|
|
biib:LoanedSecurities |
1.0 |
-3 |
[0] |
0 |
0 |
Instance |
|
|
us-gaap:InventoryNet |
1.0 |
-3 |
[6] |
268529000 |
268,529,000 |
Instance |
|
|
us-gaap:OtherAssetsCurrent |
1.0 |
-3 |
[6] |
143183000 |
143,183,000 |
Instance |
|
|
us-gaap:MarketableSecuritiesNoncurrent |
1.0 |
-3 |
[7] |
1047611000 |
1,047,611,000 |
Instance |
|
|
us-gaap:PropertyPlantAndEquipmentNet |
1.0 |
-3 |
[7] |
1608660000 |
1,608,660,000 |
Instance |
|
|
us-gaap:IntangibleAssetsNetExcludingGoodwill |
1.0 |
-3 |
[7] |
1978519000 |
1,978,519,000 |
Instance |
|
|
us-gaap:Goodwill |
1.0 |
-3 |
[7] |
1138621000 |
1,138,621,000 |
Instance |
|
|
us-gaap:OtherAssetsNoncurrent |
1.0 |
-3 |
[6] |
259507000 |
259,507,000 |
Instance |
|
| 2 |
Context
BalanceAsOf_31Dec2008
[
2008-12-31
-
]
|
| c-equal |
|
| 3 |
Unit
USD
|
| u-equal |
|
|
us-gaap:LiabilitiesAndStockholdersEquity |
|
-3 |
[7] |
8478991000 |
8,478,991,000 |
Instance |
OK |
|
us-gaap:Liabilities |
1.0 |
-3 |
[7] |
2645039000 |
2,645,039,000 |
Instance |
OK |
|
us-gaap:LiabilitiesCurrent |
1.0 |
-3 |
[6] |
923222000 |
923,222,000 |
Instance |
OK |
|
biib:CollateralPayableOnLoanedSecurities |
1.0 |
-3 |
[5] |
29991000 |
29,991,000 |
Instance |
|
|
us-gaap:AccountsPayable |
1.0 |
-3 |
[6] |
107417000 |
107,417,000 |
Instance |
|
|
us-gaap:TaxesPayable |
1.0 |
-3 |
[6] |
223260000 |
223,260,000 |
Instance |
|
|
us-gaap:OtherLiabilitiesCurrent |
1.0 |
-3 |
[6] |
534887000 |
534,887,000 |
Instance |
|
|
us-gaap:NotesPayableCurrent |
1.0 |
-3 |
[5] |
27667000 |
27,667,000 |
Instance |
|
|
us-gaap:LongTermNotesPayable |
1.0 |
-3 |
[7] |
1085431000 |
1,085,431,000 |
Instance |
|
|
us-gaap:DeferredTaxLiabilitiesNoncurrent |
1.0 |
-3 |
[6] |
356017000 |
356,017,000 |
Instance |
|
|
us-gaap:OtherLiabilitiesNoncurrent |
1.0 |
-3 |
[6] |
280369000 |
280,369,000 |
Instance |
|
|
us-gaap:StockholdersEquity |
1.0 |
-3 |
[7] |
5833952000 |
5,833,952,000 |
Instance |
OK |
|
biib:NoncontrollingInterest |
1.0 |
-3 |
[5] |
27869000 |
27,869,000 |
Instance |
|
|
biib:TotalShareholdersEquityBeforeNoncontrollingInterest |
1.0 |
-3 |
[7] |
5806083000 |
6,860,277,000 |
Instance |
Inconsistency found, calculated value is
6,860,277,000
|
|
us-gaap:AdditionalPaidInCapital |
1.0 |
-3 |
[7] |
6073957000 |
6,073,957,000 |
Instance |
|
|
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax |
1.0 |
-3 |
[5] |
-11106000 |
-11,106,000 |
Instance |
|
|
us-gaap:RetainedEarningsAccumulatedDeficit |
1.0 |
-3 |
[6] |
270180000 |
270,180,000 |
Instance |
|
|
us-gaap:TreasuryStockValue |
-1.0 |
-3 |
[6] |
-527097000 |
-527,097,000 |
Instance |
|
|
us-gaap:CommonStockValue |
1.0 |
-3 |
[3] |
149000 |
149,000 |
Instance |
|
|
us-gaap:PreferredStockValue |
1.0 |
-3 |
[0] |
0 |
0 |
Instance |
|
|
us-gaap:Assets |
|
-3 |
[7] |
8478991000 |
8,478,991,000 |
Instance |
OK |
|
us-gaap:AssetsCurrent |
1.0 |
-3 |
[7] |
2458000000 |
2,458,000,000 |
Instance |
OK |
|
us-gaap:CashAndCashEquivalentsAtCarryingValue |
1.0 |
-3 |
[6] |
622385000 |
622,385,000 |
Instance |
|
|
us-gaap:MarketableSecuritiesCurrent |
1.0 |
-3 |
[6] |
719586000 |
719,586,000 |
Instance |
|
|
biib:CollateralReceivedForLoanedSecurities |
1.0 |
-3 |
[5] |
29991000 |
29,991,000 |
Instance |
|
|
us-gaap:AccountsReceivableNetCurrent |
1.0 |
-3 |
[6] |
446665000 |
446,665,000 |
Instance |
|
|
biib:DueFromUnconsolidatedJointBusiness |
1.0 |
-3 |
[6] |
206925000 |
206,925,000 |
Instance |
|
|
biib:LoanedSecurities |
1.0 |
-3 |
[5] |
29446000 |
29,446,000 |
Instance |
|
|
us-gaap:InventoryNet |
1.0 |
-3 |
[6] |
263602000 |
263,602,000 |
Instance |
|
|
us-gaap:OtherAssetsCurrent |
1.0 |
-3 |
[6] |
139400000 |
139,400,000 |
Instance |
|
|
us-gaap:MarketableSecuritiesNoncurrent |
1.0 |
-3 |
[6] |
891406000 |
891,406,000 |
Instance |
|
|
us-gaap:PropertyPlantAndEquipmentNet |
1.0 |
-3 |
[7] |
1594754000 |
1,594,754,000 |
Instance |
|
|
us-gaap:IntangibleAssetsNetExcludingGoodwill |
1.0 |
-3 |
[7] |
2161058000 |
2,161,058,000 |
Instance |
|
|
us-gaap:Goodwill |
1.0 |
-3 |
[7] |
1138621000 |
1,138,621,000 |
Instance |
|
|
us-gaap:OtherAssetsNoncurrent |
1.0 |
-3 |
[6] |
235152000 |
235,152,000 |
Instance |
|
|
| 1 |
Extended Link [
http://biogenidec.com/20090630/StatementsOfIncome
]
|
| 2 |
Context
ThreeMonthsEnded_30Jun2009
[
2009-04-01
-
2009-06-30
]
|
| c-equal |
|
| 3 |
Unit
USD
|
| u-equal |
|
|
us-gaap:NetIncomeLoss |
|
-3 |
[6] |
142845000 |
142,845,000 |
Instance |
OK |
|
biib:ProfitLoss |
1.0 |
-3 |
[6] |
144885000 |
144,885,000 |
Instance |
OK |
|
us-gaap:IncomeTaxExpenseBenefit |
-1.0 |
-3 |
[5] |
92709000 |
92,709,000 |
Instance |
|
|
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments |
1.0 |
-3 |
[6] |
237594000 |
237,594,000 |
Instance |
OK |
|
us-gaap:OtherNonoperatingIncomeExpense |
1.0 |
-3 |
[5] |
14680000 |
14,680,000 |
Instance |
|
|
us-gaap:OperatingIncomeLoss |
1.0 |
-3 |
[6] |
222914000 |
222,914,000 |
Instance |
OK |
|
us-gaap:CostsAndExpenses |
-1.0 |
-3 |
[6] |
870375000 |
870,375,000 |
Instance |
OK |
|
us-gaap:ResearchAndDevelopmentInProcess |
1.0 |
-3 |
[0] |
0 |
0 |
Instance |
|
|
us-gaap:AmortizationOfIntangibleAssets |
1.0 |
-3 |
[5] |
93234000 |
93,234,000 |
Instance |
|
|
biib:CollaborationProfitSharing |
1.0 |
-3 |
[5] |
49138000 |
49,138,000 |
Instance |
|
|
us-gaap:SellingGeneralAndAdministrativeExpense |
1.0 |
-3 |
[6] |
220829000 |
220,829,000 |
Instance |
|
|
us-gaap:ResearchAndDevelopmentExpense |
1.0 |
-3 |
[6] |
416453000 |
416,453,000 |
Instance |
|
|
us-gaap:CostOfRevenue |
1.0 |
-3 |
[5] |
90721000 |
90,721,000 |
Instance |
|
|
us-gaap:Revenues |
1.0 |
-3 |
[7] |
1093289000 |
1,093,289,000 |
Instance |
OK |
|
us-gaap:OtherSalesRevenueNet |
1.0 |
-3 |
[5] |
26749000 |
26,749,000 |
Instance |
|
|
biib:UnconsolidatedJointBusiness |
1.0 |
-3 |
[6] |
275570000 |
275,570,000 |
Instance |
|
|
us-gaap:SalesRevenueGoodsNet |
1.0 |
-3 |
[6] |
790970000 |
790,970,000 |
Instance |
|
|
biib:NetIncomeLossAttributableToNoncontrollingInterest |
-1.0 |
-3 |
[4] |
2040000 |
2,040,000 |
Instance |
|
| 2 |
Context
ThreeMonthsEnded_30Jun2008
[
2008-04-01
-
2008-06-30
]
|
| c-equal |
|
| 3 |
Unit
USD
|
| u-equal |
|
|
us-gaap:NetIncomeLoss |
|
-3 |
[6] |
206628000 |
206,628,000 |
Instance |
OK |
|
biib:ProfitLoss |
1.0 |
-3 |
[6] |
208073000 |
208,073,000 |
Instance |
OK |
|
us-gaap:IncomeTaxExpenseBenefit |
-1.0 |
-3 |
[5] |
84706000 |
84,706,000 |
Instance |
|
|
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments |
1.0 |
-3 |
[6] |
292779000 |
292,779,000 |
Instance |
OK |
|
us-gaap:OtherNonoperatingIncomeExpense |
1.0 |
-3 |
[4] |
-4018000 |
-4,018,000 |
Instance |
|
|
us-gaap:OperatingIncomeLoss |
1.0 |
-3 |
[6] |
296797000 |
296,797,000 |
Instance |
OK |
|
us-gaap:CostsAndExpenses |
-1.0 |
-3 |
[6] |
696647000 |
696,647,000 |
Instance |
OK |
|
us-gaap:ResearchAndDevelopmentInProcess |
1.0 |
-3 |
[0] |
0 |
0 |
Instance |
|
|
us-gaap:AmortizationOfIntangibleAssets |
1.0 |
-3 |
[5] |
72869000 |
72,869,000 |
Instance |
|
|
biib:CollaborationProfitSharing |
1.0 |
-3 |
[5] |
33429000 |
33,429,000 |
Instance |
|
|
us-gaap:SellingGeneralAndAdministrativeExpense |
1.0 |
-3 |
[6] |
245689000 |
245,689,000 |
Instance |
|
|
us-gaap:ResearchAndDevelopmentExpense |
1.0 |
-3 |
[6] |
252259000 |
252,259,000 |
Instance |
|
|
us-gaap:CostOfRevenue |
1.0 |
-3 |
[5] |
92401000 |
92,401,000 |
Instance |
|
|
us-gaap:Revenues |
1.0 |
-3 |
[6] |
993444000 |
993,444,000 |
Instance |
OK |
|
us-gaap:OtherSalesRevenueNet |
1.0 |
-3 |
[5] |
30136000 |
30,136,000 |
Instance |
|
|
biib:UnconsolidatedJointBusiness |
1.0 |
-3 |
[6] |
278822000 |
278,822,000 |
Instance |
|
|
us-gaap:SalesRevenueGoodsNet |
1.0 |
-3 |
[6] |
684486000 |
684,486,000 |
Instance |
|
|
biib:NetIncomeLossAttributableToNoncontrollingInterest |
-1.0 |
-3 |
[4] |
1445000 |
1,445,000 |
Instance |
|
| 2 |
Context
SixMonthsEnded_30Jun2008
[
2008-01-01
-
2008-06-30
]
|
| c-equal |
|
| 3 |
Unit
USD
|
| u-equal |
|
|
us-gaap:NetIncomeLoss |
|
-3 |
[6] |
369725000 |
369,725,000 |
Instance |
OK |
|
biib:ProfitLoss |
1.0 |
-3 |
[6] |
373880000 |
373,880,000 |
Instance |
OK |
|
us-gaap:IncomeTaxExpenseBenefit |
-1.0 |
-3 |
[6] |
167983000 |
167,983,000 |
Instance |
|
|
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments |
1.0 |
-3 |
[6] |
541863000 |
541,863,000 |
Instance |
OK |
|
us-gaap:OtherNonoperatingIncomeExpense |
1.0 |
-3 |
[3] |
-938000 |
-938,000 |
Instance |
|
|
us-gaap:OperatingIncomeLoss |
1.0 |
-3 |
[6] |
542801000 |
542,801,000 |
Instance |
OK |
|
us-gaap:CostsAndExpenses |
-1.0 |
-3 |
[7] |
1392829000 |
1,392,829,000 |
Instance |
OK |
|
us-gaap:ResearchAndDevelopmentInProcess |
1.0 |
-3 |
[5] |
25000000 |
25,000,000 |
Instance |
|
|
us-gaap:AmortizationOfIntangibleAssets |
1.0 |
-3 |
[6] |
147650000 |
147,650,000 |
Instance |
|
|
biib:CollaborationProfitSharing |
1.0 |
-3 |
[5] |
54835000 |
54,835,000 |
Instance |
|
|
us-gaap:SellingGeneralAndAdministrativeExpense |
1.0 |
-3 |
[6] |
461518000 |
461,518,000 |
Instance |
|
|
us-gaap:ResearchAndDevelopmentExpense |
1.0 |
-3 |
[6] |
510491000 |
510,491,000 |
Instance |
|
|
us-gaap:CostOfRevenue |
1.0 |
-3 |
[6] |
193335000 |
193,335,000 |
Instance |
|
|
us-gaap:Revenues |
1.0 |
-3 |
[7] |
1935630000 |
1,935,630,000 |
Instance |
OK |
|
us-gaap:OtherSalesRevenueNet |
1.0 |
-3 |
[5] |
60029000 |
60,029,000 |
Instance |
|
|
biib:UnconsolidatedJointBusiness |
1.0 |
-3 |
[6] |
526045000 |
526,045,000 |
Instance |
|
|
us-gaap:SalesRevenueGoodsNet |
1.0 |
-3 |
[7] |
1349556000 |
1,349,556,000 |
Instance |
|
|
biib:NetIncomeLossAttributableToNoncontrollingInterest |
-1.0 |
-3 |
[4] |
4155000 |
4,155,000 |
Instance |
|
| 2 |
Context
January-01-2009_June-30-2009
[
2009-01-01
-
2009-06-30
]
|
| c-equal |
|
| 3 |
Unit
USD
|
| u-equal |
|
|
us-gaap:NetIncomeLoss |
|
-3 |
[6] |
386832000 |
386,832,000 |
Instance |
OK |
|
biib:ProfitLoss |
1.0 |
-3 |
[6] |
391464000 |
391,464,000 |
Instance |
OK |
|
us-gaap:IncomeTaxExpenseBenefit |
-1.0 |
-3 |
[6] |
157934000 |
157,934,000 |
Instance |
|
|
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments |
1.0 |
-3 |
[6] |
549398000 |
549,398,000 |
Instance |
OK |
|
us-gaap:OtherNonoperatingIncomeExpense |
1.0 |
-3 |
[5] |
21526000 |
21,526,000 |
Instance |
|
|
us-gaap:OperatingIncomeLoss |
1.0 |
-3 |
[6] |
527872000 |
527,872,000 |
Instance |
OK |
|
us-gaap:CostsAndExpenses |
-1.0 |
-3 |
[7] |
1601902000 |
1,601,902,000 |
Instance |
OK |
|
us-gaap:ResearchAndDevelopmentInProcess |
1.0 |
-3 |
[0] |
0 |
0 |
Instance |
|
|
us-gaap:AmortizationOfIntangibleAssets |
1.0 |
-3 |
[6] |
182482000 |
182,482,000 |
Instance |
|
|
biib:CollaborationProfitSharing |
1.0 |
-3 |
[5] |
91911000 |
91,911,000 |
Instance |
|
|
us-gaap:SellingGeneralAndAdministrativeExpense |
1.0 |
-3 |
[6] |
442660000 |
442,660,000 |
Instance |
|
|
us-gaap:ResearchAndDevelopmentExpense |
1.0 |
-3 |
[6] |
695931000 |
695,931,000 |
Instance |
|
|
us-gaap:CostOfRevenue |
1.0 |
-3 |
[6] |
188918000 |
188,918,000 |
Instance |
|
|
us-gaap:Revenues |
1.0 |
-3 |
[7] |
2129774000 |
2,129,774,000 |
Instance |
OK |
|
us-gaap:OtherSalesRevenueNet |
1.0 |
-3 |
[5] |
51008000 |
51,008,000 |
Instance |
|
|
biib:UnconsolidatedJointBusiness |
1.0 |
-3 |
[6] |
554388000 |
554,388,000 |
Instance |
|
|
us-gaap:SalesRevenueGoodsNet |
1.0 |
-3 |
[7] |
1524378000 |
1,524,378,000 |
Instance |
|
|
biib:NetIncomeLossAttributableToNoncontrollingInterest |
-1.0 |
-3 |
[4] |
4632000 |
4,632,000 |
Instance |
|
|